EU Speedy Review Request For J&J’s Esketamine

 
• By Maureen Kenny
  
Fast Track
EMA's accelerated assessment mechanism allows drug reviews within 150 days • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards